Article
Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache.
The journal of headache and pain - 21 Jul 2014
Schürks Markus, Frahnow Antje, Diener Hans-Christoph, Kurth Tobias, Rosskopf Dieter, Grabe Hans-Jörgen
Abstract excerpt
BACKGROUND: Triptans are only effective in terminating cluster headache (CH) attacks in 70-80% of patients. Pharmacogenetic aspects of the serotonin metabolism, specifically variation in the 5-HTTLPR may be involved. METHODS: Genetic association study in a well-defined cohort of 148 CH patients with information on drug response to triptans. CH was diagnosed according to the criteria of the International Headache...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
